Survival for lung cancer in northern Italy

Milena Sant, Gemma Gatta, Riccardo Capocaccia, Arduino Verdecchia, Anderea Micheli, Daniele Speciale, Ugo Pastorino, Franco Berrino

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

From the population covered by the Lombardy Cancer Registry (northern Italy), all 2,259 lung cancer patients diagnosed from 1976 to 1981 were followed through 30 November 1989. The length of follow-up ranged from eight to 13 years. A special investigation on long-term survivors showed that a negligible proportion (0.01 percent) of errors occur in determining life status when an active follow-up is adopted. Age, stage, and histotype were found to be statistically significant, independent, prognostic factors in multivariate analysis both by the Cox model and by a model considering the relative survival. Observed survival was 29 percent at one year after diagnosis, 13 percent at two years, eight percent at three years, five percent at five years and two percent at 10 years. Survival decreased with age, but the youngest patients of both sexes showed lower survival compared with immediately subsequent ages. Among morphologically confirmed tumors, epidermoid carcinomas and adenocarcinomas showed the highest survival (38 percent and 33 percent at one year, respectively); small cell carcinomas showed the poorest prognosis (one-year survival, 23 percent). Beyond the second year after diagnosis, differences between histotypes became slighter. Survival according to stage showed a decreasing pattern from limited to advanced tumors, one-year figures being 41 percent for localized tumors, 27 percent for regional metastasis, and three percent for distant metastasis. Relative survival in Varese was compared with that reported by other cancer registries in Western countries: the variability noted could be related to different modalities of registration and to different distribution of clinical and demographic factors.

Original languageEnglish
Pages (from-to)223-230
Number of pages8
JournalCancer Causes and Control
Volume3
Issue number3
DOIs
Publication statusPublished - May 1992

Fingerprint

Italy
Lung Neoplasms
Survival
Neoplasms
Registries
Hospital Distribution Systems
Neoplasm Metastasis
Small Cell Carcinoma
Proportional Hazards Models
Survivors
Squamous Cell Carcinoma
Adenocarcinoma
Multivariate Analysis
Demography
Population

Keywords

  • Cancer registry
  • Italy
  • lung cancer
  • survival

ASJC Scopus subject areas

  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

Sant, M., Gatta, G., Capocaccia, R., Verdecchia, A., Micheli, A., Speciale, D., ... Berrino, F. (1992). Survival for lung cancer in northern Italy. Cancer Causes and Control, 3(3), 223-230. https://doi.org/10.1007/BF00124255

Survival for lung cancer in northern Italy. / Sant, Milena; Gatta, Gemma; Capocaccia, Riccardo; Verdecchia, Arduino; Micheli, Anderea; Speciale, Daniele; Pastorino, Ugo; Berrino, Franco.

In: Cancer Causes and Control, Vol. 3, No. 3, 05.1992, p. 223-230.

Research output: Contribution to journalArticle

Sant, M, Gatta, G, Capocaccia, R, Verdecchia, A, Micheli, A, Speciale, D, Pastorino, U & Berrino, F 1992, 'Survival for lung cancer in northern Italy', Cancer Causes and Control, vol. 3, no. 3, pp. 223-230. https://doi.org/10.1007/BF00124255
Sant M, Gatta G, Capocaccia R, Verdecchia A, Micheli A, Speciale D et al. Survival for lung cancer in northern Italy. Cancer Causes and Control. 1992 May;3(3):223-230. https://doi.org/10.1007/BF00124255
Sant, Milena ; Gatta, Gemma ; Capocaccia, Riccardo ; Verdecchia, Arduino ; Micheli, Anderea ; Speciale, Daniele ; Pastorino, Ugo ; Berrino, Franco. / Survival for lung cancer in northern Italy. In: Cancer Causes and Control. 1992 ; Vol. 3, No. 3. pp. 223-230.
@article{fa90aba4b1f641708f5568a674e38099,
title = "Survival for lung cancer in northern Italy",
abstract = "From the population covered by the Lombardy Cancer Registry (northern Italy), all 2,259 lung cancer patients diagnosed from 1976 to 1981 were followed through 30 November 1989. The length of follow-up ranged from eight to 13 years. A special investigation on long-term survivors showed that a negligible proportion (0.01 percent) of errors occur in determining life status when an active follow-up is adopted. Age, stage, and histotype were found to be statistically significant, independent, prognostic factors in multivariate analysis both by the Cox model and by a model considering the relative survival. Observed survival was 29 percent at one year after diagnosis, 13 percent at two years, eight percent at three years, five percent at five years and two percent at 10 years. Survival decreased with age, but the youngest patients of both sexes showed lower survival compared with immediately subsequent ages. Among morphologically confirmed tumors, epidermoid carcinomas and adenocarcinomas showed the highest survival (38 percent and 33 percent at one year, respectively); small cell carcinomas showed the poorest prognosis (one-year survival, 23 percent). Beyond the second year after diagnosis, differences between histotypes became slighter. Survival according to stage showed a decreasing pattern from limited to advanced tumors, one-year figures being 41 percent for localized tumors, 27 percent for regional metastasis, and three percent for distant metastasis. Relative survival in Varese was compared with that reported by other cancer registries in Western countries: the variability noted could be related to different modalities of registration and to different distribution of clinical and demographic factors.",
keywords = "Cancer registry, Italy, lung cancer, survival",
author = "Milena Sant and Gemma Gatta and Riccardo Capocaccia and Arduino Verdecchia and Anderea Micheli and Daniele Speciale and Ugo Pastorino and Franco Berrino",
year = "1992",
month = "5",
doi = "10.1007/BF00124255",
language = "English",
volume = "3",
pages = "223--230",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer International Publishing AG",
number = "3",

}

TY - JOUR

T1 - Survival for lung cancer in northern Italy

AU - Sant, Milena

AU - Gatta, Gemma

AU - Capocaccia, Riccardo

AU - Verdecchia, Arduino

AU - Micheli, Anderea

AU - Speciale, Daniele

AU - Pastorino, Ugo

AU - Berrino, Franco

PY - 1992/5

Y1 - 1992/5

N2 - From the population covered by the Lombardy Cancer Registry (northern Italy), all 2,259 lung cancer patients diagnosed from 1976 to 1981 were followed through 30 November 1989. The length of follow-up ranged from eight to 13 years. A special investigation on long-term survivors showed that a negligible proportion (0.01 percent) of errors occur in determining life status when an active follow-up is adopted. Age, stage, and histotype were found to be statistically significant, independent, prognostic factors in multivariate analysis both by the Cox model and by a model considering the relative survival. Observed survival was 29 percent at one year after diagnosis, 13 percent at two years, eight percent at three years, five percent at five years and two percent at 10 years. Survival decreased with age, but the youngest patients of both sexes showed lower survival compared with immediately subsequent ages. Among morphologically confirmed tumors, epidermoid carcinomas and adenocarcinomas showed the highest survival (38 percent and 33 percent at one year, respectively); small cell carcinomas showed the poorest prognosis (one-year survival, 23 percent). Beyond the second year after diagnosis, differences between histotypes became slighter. Survival according to stage showed a decreasing pattern from limited to advanced tumors, one-year figures being 41 percent for localized tumors, 27 percent for regional metastasis, and three percent for distant metastasis. Relative survival in Varese was compared with that reported by other cancer registries in Western countries: the variability noted could be related to different modalities of registration and to different distribution of clinical and demographic factors.

AB - From the population covered by the Lombardy Cancer Registry (northern Italy), all 2,259 lung cancer patients diagnosed from 1976 to 1981 were followed through 30 November 1989. The length of follow-up ranged from eight to 13 years. A special investigation on long-term survivors showed that a negligible proportion (0.01 percent) of errors occur in determining life status when an active follow-up is adopted. Age, stage, and histotype were found to be statistically significant, independent, prognostic factors in multivariate analysis both by the Cox model and by a model considering the relative survival. Observed survival was 29 percent at one year after diagnosis, 13 percent at two years, eight percent at three years, five percent at five years and two percent at 10 years. Survival decreased with age, but the youngest patients of both sexes showed lower survival compared with immediately subsequent ages. Among morphologically confirmed tumors, epidermoid carcinomas and adenocarcinomas showed the highest survival (38 percent and 33 percent at one year, respectively); small cell carcinomas showed the poorest prognosis (one-year survival, 23 percent). Beyond the second year after diagnosis, differences between histotypes became slighter. Survival according to stage showed a decreasing pattern from limited to advanced tumors, one-year figures being 41 percent for localized tumors, 27 percent for regional metastasis, and three percent for distant metastasis. Relative survival in Varese was compared with that reported by other cancer registries in Western countries: the variability noted could be related to different modalities of registration and to different distribution of clinical and demographic factors.

KW - Cancer registry

KW - Italy

KW - lung cancer

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=0026758218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026758218&partnerID=8YFLogxK

U2 - 10.1007/BF00124255

DO - 10.1007/BF00124255

M3 - Article

VL - 3

SP - 223

EP - 230

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 3

ER -